This episode tackles a novel problem in obesity medicine: GLP-1 receptor agonists and similar medications can now produce weight loss so dramatic that doctors face an unprecedented question—when should treatment stop? Hosted by Holly and Jim (credentials not specified in notes), the episode uses a patient case study…
Worth it if you're on GLP-1 medications, prescribe them, or want to understand how modern obesity treatment has shifted from simple weight loss to nuanced optimization.